Drug shortages: Study examines pandemic supply chain, HHS proposes resilience incentive

While drug shortages worsened due to supply chain issues at the start of the COVID-19 pandemic, they quickly returned to pre-pandemic levels, according to research published on 5 April in JAMA. The study also found that one in seven supply chain issue reports, or 14%, were associated with drug shortages.